In vitro transfection of B16 (melanoma) and CT26 (colon carcinoma) tumor cells with MLKL or tBID was achieved using LipofectamineTM as a transfection agent, while in vivo delivery of the mRNA was achieved through electroporation. Here, MLKL is linked to neoplasm.